We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

101 hedge funds and large institutions have $87.9M invested in iShares US Pharmaceuticals ETF in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

2% more funds holding

Funds holding: 99 → 101 (+2)

3% less capital invested

Capital invested by funds: $91M → $87.9M (-$3.08M)

1.81% less ownership

Funds ownership: 76.05% → 74.23% (-1.8%)

39% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 31

Holders
101
Holders Change
+2
Holders Change %
+2.02%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
19
Reduced
31
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wells Fargo
Wells Fargo
California
+$5.44M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.95M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.68M
4
RJA
Raymond James & Associates
Florida
+$458K
5
LPL Financial
LPL Financial
California
+$327K

Top Sellers

1
TRCT
Tower Research Capital (TRC)
New York
-$6.32M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.61M
3
CG
Colony Group
Massachusetts
-$1.01M
4
PAG
Pinnacle Advisory Group
Maryland
-$713K
5
Morgan Stanley
Morgan Stanley
New York
-$357K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
1
Wells Fargo
California
$9.1M +$5.44M +90,177 +142%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$8.76M +$1.68M +27,861 +23%
Morgan Stanley
3
Morgan Stanley
New York
$7.5M -$357K -5,913 -4%
Brown Advisory
4
Brown Advisory
Maryland
$7.13M – – –
Bank of America
5
Bank of America
North Carolina
$5.92M -$123K -2,043 -2%
RJA
6
Raymond James & Associates
Florida
$4.85M +$458K +7,587 +10%
LPL Financial
7
LPL Financial
California
$4.59M +$327K +5,421 +8%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$4.39M +$2.95M +48,939 +195%
MCM
9
Murphy Capital Management
New Jersey
$3.39M -$15.4K -255 -0.4%
SPIA
10
Steward Partners Investment Advisory
New York
$2.68M -$332K -5,505 -11%
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$2.67M -$6.88K -114 -0.3%
UBS Group
12
UBS Group
Switzerland
$1.96M -$243K -4,032 -11%
Envestnet Asset Management
13
Envestnet Asset Management
Illinois
$1.77M -$13.2K -219 -0.7%
Fisher Asset Management
14
Fisher Asset Management
Washington
$1.55M -$99K -1,641 -6%
Truist Financial
15
Truist Financial
North Carolina
$1.28M -$6.33K -105 -0.5%
CFA
16
Cahill Financial Advisors
Minnesota
$1.25M -$5.97K -99 -0.5%
ST
17
Spinnaker Trust
Maine
$1.2M -$58.8K -975 -5%
PP
18
Patten & Patten
Tennessee
$1.07M -$13.6K -225 -1%
WIA
19
Wealthstreet Investment Advisors
Texas
$1.06M +$11.4K +189 +1%
Janney Montgomery Scott
20
Janney Montgomery Scott
Pennsylvania
$1.05M +$5.43K +90 +0.5%
Osaic Holdings
21
Osaic Holdings
Arizona
$1.05M -$126K -2,082 -10%
TYCC
22
Texas Yale Capital Corp
Florida
$854K – – –
AMG
23
Asset Management Group
Connecticut
$701K – – –
RJFSA
24
Raymond James Financial Services Advisors
Florida
$690K +$47.8K +792 +7%
TFF
25
The Family Firm
Maryland
$683K +$181 +3 +0%
1
2 3 4 5

IHE Hedge Fund Activity: Q1 2021 in Review

101 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2021, worth a combined $87.9M — down 3.4% from $91M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IHE positions and 9 closed out — a net gain of 3 holders — while 19 added to existing stakes and 31 trimmed.

The largest buyer was Wells Fargo, adding an estimated $5.44M. The largest seller was Tower Research Capital (TRC), cutting an estimated $6.32M.

  • 101 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2021, up from 99 in Q4 2020.
  • Funds reported $87.9M of iShares US Pharmaceuticals ETF stock for Q1 2021, down 3.4% quarter-over-quarter.
  • 12 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2021 and 9 closed out, a net change of +3 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q1 2021 was Wells Fargo, an estimated $5.44M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q1 2021 was Tower Research Capital (TRC), an estimated $6.32M sold.

Based on aggregated 13F filings for Q1 2021.